Summary:
A 12 week , Phase 2 Randomized, Placebo controlled Double blind study to asses the Efficacy, Safety and tolerability of an investigational medication in subjects with severely elevated triglecerides.
Qualified Participants Must:
• Have High Triglycerides
Qualified Participants May Receive:
Compensation for time and travel.